Literature DB >> 26278725

Terminating observation within matched pairs of subjects in a matched cohort analysis: a Monte Carlo simulation study.

Rinku Sutradhar1,2,3, Nancy N Baxter1,2,4, Peter C Austin1,2.   

Abstract

Matched cohort analyses are becoming increasingly popular for estimating treatment effects in observational studies. However, in the applied biomedical literature, analysts and authors are inconsistent regarding whether to terminate follow-up among members of a matched set once one member is no longer under observation. This paper focused on time-to-event outcomes and used Monte Carlo simulation methods to determine the optimal approach. We found that the bias of the estimated treatment effect estimate was negligible under both approaches and that the percentage of censoring had no discernible effect on the magnitude of bias. The mean model-based standard error of the treatment estimate was consistently higher when we terminated observation within matched pairs. Furthermore, the type 1 error rate was consistently lower when we did not terminate follow-up within matched pairs. In conclusion, when the focus was on time-to-event outcomes, we demonstrated that there was no advantage to terminating follow-up within matched pairs. Continuing follow-up on each subject until their observation was naturally complete was superior compared with terminating a subject's observation time once its matched pair had ceased to be under observation. Given the frequency with which these analyses are conducted in the applied literature, our results provide important guidance to analysts and applied researchers as to the preferred analytic approach.
Copyright © 2015 John Wiley & Sons, Ltd.

Keywords:  Monte Carlo simulations; bias; censoring; matched cohort study; terminate follow-up; treatment effect

Mesh:

Year:  2015        PMID: 26278725     DOI: 10.1002/sim.6621

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancer.

Authors:  James W S Young; Rinku Sutradhar; Jagadish Rangrej; Connie Marras; Neil Fleshner; Shabbir M H Alibhai
Journal:  World J Urol       Date:  2017-02-15       Impact factor: 4.226

2.  Evaluation of the US Food and Drug Administration Sentinel Analysis Tools Using a Comparator with a Different Indication: Comparing the Rates of Gastrointestinal Bleeding in Warfarin and Statin Users.

Authors:  Ryan M Carnahan; Joshua J Gagne; Christian Hampp; Charles E Leonard; Sengwee Toh; Candace C Fuller; Sean Hennessy; Laura Hou; Noelle M Cocoros; Genna Panucci; Tiffany Woodworth; Austin Cosgrove; Aarthi Iyer; Elizabeth A Chrischilles
Journal:  Pharmaceut Med       Date:  2019-02

3.  Do Primary Care Provider Strategies Improve Patient Participation in Colorectal Cancer Screening?

Authors:  Nancy N Baxter; Rinku Sutradhar; Qing Li; Corinne Daly; Gladys N Honein-AbouHaidar; Devon P Richardson; Lisa Del Giudice; Jill Tinmouth; Lawrence Paszat; Linda Rabeneck
Journal:  Am J Gastroenterol       Date:  2017-02-28       Impact factor: 10.864

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.